422 related articles for article (PubMed ID: 19286961)
1. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
[TBL] [Abstract][Full Text] [Related]
2. How does Viagra protect the ischemic heart?
Xia Y
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1209-10. PubMed ID: 19346460
[No Abstract] [Full Text] [Related]
3. Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats.
Choi DE; Jeong JY; Lim BJ; Chung S; Chang YK; Lee SJ; Na KR; Kim SY; Shin YT; Lee KW
Am J Physiol Renal Physiol; 2009 Aug; 297(2):F362-70. PubMed ID: 19474186
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta.
Das A; Xi L; Kukreja RC
J Biol Chem; 2008 Oct; 283(43):29572-85. PubMed ID: 18723505
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart.
Salloum F; Yin C; Xi L; Kukreja RC
Circ Res; 2003 Apr; 92(6):595-7. PubMed ID: 12637371
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling.
Das A; Xi L; Kukreja RC
J Biol Chem; 2005 Apr; 280(13):12944-55. PubMed ID: 15668244
[TBL] [Abstract][Full Text] [Related]
7. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective PKG-independent NO signaling at reperfusion.
Cohen MV; Yang XM; Liu Y; Solenkova NV; Downey JM
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2028-36. PubMed ID: 20852051
[TBL] [Abstract][Full Text] [Related]
10. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
[TBL] [Abstract][Full Text] [Related]
11. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection.
Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D
Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215
[TBL] [Abstract][Full Text] [Related]
12. Activation of cGMP/protein kinase G pathway in postconditioned myocardium depends on reduced oxidative stress and preserved endothelial nitric oxide synthase coupling.
Inserte J; Hernando V; Vilardosa Ú; Abad E; Poncelas-Nozal M; Garcia-Dorado D
J Am Heart Assoc; 2013 Jan; 2(1):e005975. PubMed ID: 23525447
[TBL] [Abstract][Full Text] [Related]
13. Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases.
Ruusalepp A; Czibik G; Flatebø T; Vaage J; Valen G
Basic Res Cardiol; 2007 Jul; 102(4):318-26. PubMed ID: 17268885
[TBL] [Abstract][Full Text] [Related]
14. Sevoflurane post-conditioning protects isolated rat hearts against ischemia-reperfusion injury via activation of the ERK1/2 pathway.
Xie H; Zhang J; Zhu J; Liu LX; Rebecchi M; Hu SM; Wang C
Acta Pharmacol Sin; 2014 Dec; 35(12):1504-13. PubMed ID: 25345742
[TBL] [Abstract][Full Text] [Related]
15. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
16. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G
Basic Res Cardiol; 2014 Jul; 109(4):418. PubMed ID: 24859929
[TBL] [Abstract][Full Text] [Related]
18. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
[TBL] [Abstract][Full Text] [Related]
19. Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection.
Jamnicki-Abegg M; Weihrauch D; Chiari PC; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
J Cardiovasc Pharmacol; 2007 Dec; 50(6):670-6. PubMed ID: 18091584
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
